ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

Bypass Budget Will Call For 15-percent Increase

February 18, 2011

The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress

October 31, 1986

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006